1. Home
  2. VKTX vs VRN Comparison

VKTX vs VRN Comparison

Compare VKTX & VRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • VRN
  • Stock Information
  • Founded
  • VKTX 2012
  • VRN 1994
  • Country
  • VKTX United States
  • VRN Canada
  • Employees
  • VKTX N/A
  • VRN N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • VRN Oil & Gas Production
  • Sector
  • VKTX Health Care
  • VRN Energy
  • Exchange
  • VKTX Nasdaq
  • VRN Nasdaq
  • Market Cap
  • VKTX 3.4B
  • VRN 3.2B
  • IPO Year
  • VKTX 2015
  • VRN N/A
  • Fundamental
  • Price
  • VKTX $34.07
  • VRN $5.01
  • Analyst Decision
  • VKTX Strong Buy
  • VRN Strong Buy
  • Analyst Count
  • VKTX 14
  • VRN 2
  • Target Price
  • VKTX $97.29
  • VRN $11.50
  • AVG Volume (30 Days)
  • VKTX 4.8M
  • VRN 16.7M
  • Earning Date
  • VKTX 02-05-2025
  • VRN 02-27-2025
  • Dividend Yield
  • VKTX N/A
  • VRN 6.68%
  • EPS Growth
  • VKTX N/A
  • VRN N/A
  • EPS
  • VKTX N/A
  • VRN 1.31
  • Revenue
  • VKTX N/A
  • VRN $2,851,178,799.00
  • Revenue This Year
  • VKTX N/A
  • VRN $31.20
  • Revenue Next Year
  • VKTX $986.87
  • VRN N/A
  • P/E Ratio
  • VKTX N/A
  • VRN $3.81
  • Revenue Growth
  • VKTX N/A
  • VRN 23.15
  • 52 Week Low
  • VKTX $28.64
  • VRN $4.39
  • 52 Week High
  • VKTX $99.41
  • VRN $9.28
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 51.41
  • VRN 47.64
  • Support Level
  • VKTX $28.90
  • VRN $5.14
  • Resistance Level
  • VKTX $34.37
  • VRN $5.38
  • Average True Range (ATR)
  • VKTX 2.37
  • VRN 0.17
  • MACD
  • VKTX 0.66
  • VRN 0.00
  • Stochastic Oscillator
  • VKTX 70.06
  • VRN 55.92

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About VRN Veren Inc. Common shares

Veren Inc is an oil producer company. It is engaged in acquiring, developing, and holding interests in petroleum assets operations across western Canada.

Share on Social Networks: